Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP... see more

TSXV:HEM - Post Discussion

Hemostemix Inc > It will be hard to get size post rollback
View:
Post by Pimpovish on Dec 29, 2020 1:33pm

It will be hard to get size post rollback

This is why i personally followed in the path of a very large whale. This is not a whimsical stock story. Its real tech. Very real. Look at the stem sell sector. Valuations run into the billions. HEM is not some mere startup but an intermediate opportunity that is evolving. If this company was currently listed on Nasdaq it would arguably be valued anywhere from $250 million US to a billion plus. I look at these pricing levels as an interval for massive future wealth creation. Everyone has their own investment agenda. Its ok to make a shilling but even better to make a killing.
Comment by Justcall6969 on Dec 29, 2020 1:47pm
100% agree
Comment by Duedilligence10 on Dec 29, 2020 1:47pm
Agreed, by this time next year we will be lauging at the one-cent movements in the SP.  No doubt, stem cell therepay is a massive untaped market.  HEM's process is not invasive and is highly effective.  That's why the old "management team" tried to steal it and that is why Smeenk fought tooth and nail to wrestle it back.  They know they are sitting on a gold ...more  
Comment by TheBullishGuy on Dec 29, 2020 2:24pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse